Follow
Scott Bagley
Scott Bagley
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Application of fundamental organometallic chemistry to the development of a gold‐catalyzed synthesis of sulfinate derivatives
MW Johnson, SW Bagley, NP Mankad, RG Bergman, V Mascitti, FD Toste
Angewandte Chemie International Edition 53 (17), 4404-4407, 2014
2452014
One-pot palladium-catalyzed synthesis of sulfonyl fluorides from aryl bromides
AT Davies, JM Curto, SW Bagley, MC Willis
Chemical Science 8 (2), 1233-1237, 2017
1752017
Decarboxylative cross-nucleophile coupling via ligand-to-metal charge transfer photoexcitation of Cu(ii) carboxylates
QY Li, SN Gockel, GA Lutovsky, KS DeGlopper, NJ Baldwin, ...
Nature chemistry 14 (1), 94-99, 2022
1102022
Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetes
DA Griffith, DW Kung, WP Esler, PA Amor, SW Bagley, C Beysen, ...
Journal of medicinal chemistry 57 (24), 10512-10526, 2014
832014
Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
SW Bagley, PK Chakravarty, A Chen, DS Dhanoa, KJ Fitch, WJ Greenlee, ...
US Patent 5,334,598, 1994
821994
Cyclic Alkenylsulfonyl Fluorides: Palladium‐Catalyzed Synthesis and Functionalization of Compact Multifunctional Reagents
TSB Lou, SW Bagley, MC Willis
Angewandte Chemie 131 (52), 19035-19039, 2019
812019
A small-molecule oral agonist of the human glucagon-like peptide-1 receptor
DA Griffith, DJ Edmonds, JP Fortin, AS Kalgutkar, JB Kuzmiski, PM Loria, ...
Journal of Medicinal Chemistry 65 (12), 8208-8226, 2022
702022
Discovery of 2-(6-(5-Chloro-2-methoxyphenyl)-4-oxo-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamide (PF-06282999): A Highly Selective Mechanism-Based …
RB Ruggeri, L Buckbinder, SW Bagley, PA Carpino, EL Conn, ...
Journal of medicinal chemistry 58 (21), 8513-8528, 2015
542015
Phenoxyphenylacetic acid derivatives
SW Bagley, TP Broten, PK Chakravarty, DS Dhanoa, KJ Fitch, ...
US Patent 5,668,176, 1997
481997
Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based Antidiabetic Treatment
M Ammirati, SW Bagley, SK Bhattacharya, L Buckbinder, AA Carlo, ...
ACS medicinal chemistry letters 6 (11), 1128-1133, 2015
432015
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure
DA Griffith, RL Dow, K Huard, DJ Edmonds, SW Bagley, J Polivkova, ...
Journal of medicinal chemistry 56 (17), 7110-7119, 2013
422013
Non-peptide angiotensin II receptor antagonists. 1. Design, synthesis, and biological activity of N-substituted indoles and dihydroindoles
DS Dhanoa, SW Bagley, RSL Chang, VJ Lotti, TB Chen, SD Kivlighn, ...
Journal of medicinal chemistry 36 (26), 4230-4238, 1993
421993
Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors
SK Bhattacharya, GE Aspnes, SW Bagley, M Boehm, AD Brosius, ...
Bioorganic & medicinal chemistry letters 22 (24), 7523-7529, 2012
352012
A critical role for peroxisomal proliferator-activated receptor-α nuclear receptors in the development of cardiomyocyte degeneration and necrosis
I Pruimboom-Brees, M Haghpassand, L Royer, D Brees, C Aldinger, ...
The American journal of pathology 169 (3), 750-760, 2006
342006
Synthesis of spiropiperidine lactam acetyl-CoA carboxylase inhibitors
K Huard, SW Bagley, E Menhaji-Klotz, C Préville, JA Southers Jr, ...
The Journal of organic chemistry 77 (22), 10050-10057, 2012
312012
N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
SW Bagley, DA Griffith, DWS Kung
US Patent 8,288,405, 2012
292012
(Dipropylphenoxy) phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists
DS Dhanoa, SW Bagley, RSL Chang, VJ Lotti, TB Chen, SD Kivlighn, ...
Journal of medicinal chemistry 36 (23), 3738-3742, 1993
291993
Short-acting 5-(trifluoromethyl) pyrido [4, 3-d] pyrimidin-4 (3H)-one derivatives as orally-active calcium-sensing receptor antagonists
MT Didiuk, DA Griffith, JW Benbow, KKC Liu, DP Walker, FC Bi, J Morris, ...
Bioorganic & medicinal chemistry letters 19 (16), 4555-4559, 2009
282009
Discovery Tactics To Mitigate Toxicity Risks Due to Reactive Metabolite Formation with 2-(2-Hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one …
AS Kalgutkar, DA Griffith, T Ryder, H Sun, Z Miao, JN Bauman, MT Didiuk, ...
Chemical research in toxicology 23 (6), 1115-1126, 2010
272010
Biphenyl compounds useful or endothelin antagonists
SW Bagley, TP Broten, PK Chakravarty, DS Dhanoa, KJ Fitch, ...
US Patent 5,565,485, 1996
271996
The system can't perform the operation now. Try again later.
Articles 1–20